TOP TIERMARKET NEWSWIRE
SEC Form 4 history

XENON PHARMACEUTICAL (XENE) insider trades

XENON PHARMACEUTICAL (XENE) insider trading activity (SEC Form 4). Over the trailing 90 days, XENE insiders filed 2 purchases totalling $1.7M and 2 sales totalling $1.1M — net BUYING of $615K. Most recent filing: Oct 1, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
2
$1.7M
Sells (90d)
2
$1.1M
Net (90d)
+$615K
net buying
Most recent
Oct 1, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Oct 1, 2026Kelly Thomas PatrickCFOP Purchase—$37.32$560Kfiling
Oct 1, 2026Mortimer IanPres, CEOP Purchase—$37.38$1.1Mfiling
Aug 31, 2026Kenney Christopher JohnChief Medical OfficerS Sale—$60.25$426Kfiling
Aug 13, 2026Gannon StevenDirS Sale—$64.06$641Kfiling
Jun 8, 2026Cannon GillianDirS Sale—$53.14$63Kfiling
Jun 8, 2026Patou GaryDirS Sale—$53.14$70Kfiling